ct of the liver with pre-contrast & triphasic contrast enhancement studies show:
  

brief hx: a 76 y/o male suspicious liver nodule 

this study has been compared to previous ct on 20190610

techniques: 
from lower chest to liver inferior edge in 5-mm contiguous section 
contrast agent  injected at 2ml/sec, 30 sec after initiation of injection, 
starting arterial phase scan; portal phase scan performed in 20 sec after the 
end of the arterial phase scan; and venous phase scan began in 20 sec after the 
end of portal phase scan

findings:

several newfound pulmonary nodules in rll (up to 23 mm) and rml, suggesting lung
 metastases.
no definite space occupying lesion in the spleen and pancreas.
lobulated contour of liver compatible with liver cirrhosis. 
a 3.1 cm early enhancement and early washout nodule with necrosis in s8 liver, 
favoring hcc.
no definite biliary dilatation .
unremarkable study of gallbladder 
patency of portal vein  
bilateral renal cysts, the biggest one at the left with size of 4.6 cm . 
normal function and contour of bil. kidneys and no definite obstructive uropathy
.
no definite enlargement of retroperitoneal lns  .
no abnormal fluid collection in the abdomen.
s/p laminectomy of l spine
enlarged prostate with heterogenous enhancement
multiple diverticula at a-colon .
kindly note that subtle mucosal lesion could not be well evaluated on routine ct
. 

imp:
* several newfound pulmonary nodules in rll (up to 23 mm) and rml, suggesting 
lung metastases.
* a 3.1 cm early enhancement and early washout nodule with central necrosis in s
8 liver, favoring hcc.

¡´imaging report form for hepatocellua carcinoma (ajcc 8th edition)
1.tumor number/location: 
number: ¡´1 ¡³2 ¡³3 multiple:
location: s8 
2.tumor size: 
    ¡´measurable: 3.1cm (the largest tumor)
    ¡³non-measurable
3.tumor characteristics and associated liver features
    ¡³vascular invasion 
    ¡³extrahepatic spread 
    ¡³ascites 
    ¡³portal vein thrombosis, location 
    ¡³portosystemic collateral vessel
    ¡´typical enhancement pattern (hypervascular enhancement and early wash-out)
3.pathology: ¡³not available ¡´available (pathology type:hcc)

-------------------primary tumor(t)--------------------------
 tx  ¡³ primary tumor cannot be assessed 
 t0  ¡³ no primary tumor 
stage i
t1   ¡³ solitary tumor ¡Ø2 cm, or > 2cm without vascular invasion
t1a  solitary tumor ¡Ø2 cm
t1b  ¡´solitary tumor > 2cm without vascular invasion
stage ii
t2   ¡³ solitary tumor >2cm with vascular invasion, or multiple tumors,none >5
cm 
stage iii
t3   ¡³multiple tumors more than 5 cm 
t4   ¡³tsingle tumor or multiple tumors of any size involving a major
branch of the portal vein or hepatic vein, or tumor(s) with direct
invasion of adjacent organs other than the gallbladder or with
perforation of visceral peritoneum 
-------------------regional lymph nodes(n)-----------------
nx   ¡³regional lymph nodes cannot be assessed 
n0   ¡´no regional lymph nodes
stage iva
n1   ¡³regional lymph node metastasis 
     ¡³periceliac, ¡³hilar( common bile duct, hepatic artery, portal vein and 
cystic duct) ¡³peripancreatic ¡³paraaortic ¡³portocaval ¡³retrocaval
¡³others_______ 
-------------------distant metastasis(m)----------------------
stage ivb
m1  ¡´distant metastasis
¡³	invasion of gallbladder
¡³	cardiophrenic, mesenteric, retrocrural ln
imaging stage   t1b-2 n0( in this study)
